Back to Incidents Registry
SEC-CMS-2018-0314FDA REGISTRYBiomedical Diagnostic Technology

Theranos Edison: Microtainer Fingerstick Dilution & Commercial Analyzer Modification

Incident Failure Topology Brief
Catastrophic (Level 5)Sev 9.7/10

Diagnostic telemetry capability was completely fabricated. Internal Decision_Nodes diluted physical biological samples to run on concealed third-party machines, deliberately concealing failure state from patients and regulators.

Failure Invariant Breach
Total corporate liquidation & criminal fraud
Absent Safety Recovery Mechanism
Mandatory direct whistle-blower escalation path to federal safety regulators
Domain De-Aliasing & Jargon Stripping
Raw Domain Record (Subjective Narrative)

Theranos claimed its proprietary "Edison" and "miniLab" devices could run hundreds of clinical lab tests from a single drop of capillary blood. In reality, the microfluidics technology failed basic precision and accuracy standards. To conceal the defect, Theranos diluted capillary blood samples with saline and ran them on modified third-party Siemens and Beckman Coulter commercial analyzers, producing inaccurate diagnostic results for thousands of cancer, diabetes, and potassium patients.

PatternDB Invariant Representation

Diagnostic telemetry capability was completely fabricated. Internal Decision_Nodes diluted physical biological samples to run on concealed third-party machines, deliberately concealing failure state from patients and regulators.

Causal Failure Topology & State Vectors
4 Sequential Invariant Breaches
STEP 01DEGRADE
Proprietary_Edison_Device

Failed 88% of quality control audits due to erratic microfluidic pipetting

Vector: Physical technology failure
STEP 02DEGRADE
Lab_Management

Diluted fingerstick blood samples up to 10x with saline, creating severe analytical noise

Vector: Sample dilution boundary violation
STEP 03DEGRADE
Concealed_Siemens_Machines

Executed diluted tests on commercial machines while claiming Edison performed tests

Vector: Deliberate telemetry falsification
STEP 04RUPTURE
CMS_Inspectors

Revoked clinical laboratory license, voided 2 years of blood test results, and indicted executives

Vector: Total corporate liquidation & criminal fraud
Decision Nodes Involved
Theranos Executive Leadership
Clinical Lab Directors
FDA/CMS Health Inspectors
Telemetry Channels
Clinical Lab Proficiency Testing (PT) Blinded Samples
Patient Blood Diagnostic Reports
Constraint Boundaries Breached
CLIA Clinical Laboratory Diagnostic Accuracy & Precision Invariant (< 5% Coeff of Variation)
Official Regulatory Audit Citation
FDA RegistrySEC-CMS-2018-0314
Incident Official DateMar 14, 2018
Quantified Systemic Loss$9,000,000,000 Enterprise Valuation Evaporation & Multi-Year Prison Sentences
Primary Investigation Transcripts:

"Theranos routinely diluted capillary blood samples so they could be run on modified commercial machines."

Immutable Archive RecordVerify at FDA Primary Database

Cross-Domain Invariant Twin Failures (56)

Cross-Domain Invariant Twin
100% Topological MatchΔ 0.000
SEC-CMS-2018-0314Biomedical Diagnostic Technology
Theranos Edison: Microtainer Fingerstick Dilution & Commercial Analyzer Modification

Diagnostic telemetry capability was completely fabricated. Internal Decision_Nodes diluted physical biological samples to run on concealed third-party machines, deliberately concealing failure state from patients and regulators.

Source Authority:FDA
NHTSA-DOJ-2014-0516Automotive & Consumer Product Safety
General Motors Cobalt Ignition Switch Torque Defect & Airbag Disable Concealment

Internal testing detected critical failure mode in primary control hardware. Decision_Nodes siloed defect records and modified manufacturing telemetry (silent part revision) to avoid recall liability while exterior channels reported nominal compliance.

Source Authority:NHTSA
Shared Failure Vector: Component_Test_Failure -> Product_Investigation_Committee (Concealed) -> Executive_Suite (Blind) -> Public_Crashes
Deep Compare
Cross-Domain Invariant Twin
100% Topological MatchΔ 0.000
SEC-CMS-2018-0314Biomedical Diagnostic Technology
Theranos Edison: Microtainer Fingerstick Dilution & Commercial Analyzer Modification

Diagnostic telemetry capability was completely fabricated. Internal Decision_Nodes diluted physical biological samples to run on concealed third-party machines, deliberately concealing failure state from patients and regulators.

Source Authority:FDA
NHTSA-DOJ-2015-1103Automotive Safety Engineering
Takata Airbag Inflator Phase-Stabilized Ammonium Nitrate Chemical Degradation

Material cost optimization substituted safe chemical buffer for volatile compound. Latent chemical degradation altered physical State_Telemetry without external outward indicators, causing explosive canister rupture under nominal deployment triggers.

Source Authority:NHTSA
Shared Failure Vector: Component_Test_Failure -> Product_Investigation_Committee (Concealed) -> Executive_Suite (Blind) -> Public_Crashes
Deep Compare
Cross-Domain Invariant Twin
100% Topological MatchΔ 0.125
SEC-CMS-2018-0314Biomedical Diagnostic Technology
Theranos Edison: Microtainer Fingerstick Dilution & Commercial Analyzer Modification

Diagnostic telemetry capability was completely fabricated. Internal Decision_Nodes diluted physical biological samples to run on concealed third-party machines, deliberately concealing failure state from patients and regulators.

Source Authority:FDA
BEA-AAR-2000-0725Commercial Supersonic Aviation
Air France Flight 4590: Concorde Runway Titanium Strip Fuel Tank Hydrodynamic Shock

Tire fragment transmitted hydraulic kinetic wave through liquid fuel Buffer_Reserve. Fuel tank skin Constraint_Boundary failed from interior hydrostatic pressure pulse, severing engine thrust channels.

Source Authority:FAA
Shared Failure Vector: Component_Test_Failure -> Product_Investigation_Committee (Concealed) -> Executive_Suite (Blind) -> Public_Crashes
Deep Compare